Weicore Biotechnology: Raises nearly 950 million and signs tripartite regulatory agreement with specific targets.

Micro-Core Biology announced that the company issued 35.1331 million shares to specific objects, raising a total of 949 million yuan. After deducting the issuance expenses, the net amount was 932 million yuan, all of which were in place on February 12, 2026. In order to regulate fund management, the company recently signed a "Fundraising Three-party Supervision Agreement" with five banks including Guotou Securities in Shenzhen and China CITIC Bank Shenzhen Branch in Shenzhen, clarifying the rights and obligations of all parties. The agreement will take effect upon signing and expire when the special account funds are disbursed, the account is closed legally, and the supervision period ends.